Full text
PDFPage 949
. 1984 Dec;26(6):949.
In Vitro Evaluation of HR810, a New Wide-Spectrum Aminothiazolyl α-Methoxyimino Cephalosporin
Ronald N Jones
1, Clyde Thornsberry
1, Arthur L Barry
1
Ronald N Jones
1Department of Pathology, Kaiser-Permanente Medical Care Program (Oregon Region), Clackamas, Oregon 97015; Centers for Disease Control, Atlanta, Georgia 30333; and The Clinical Microbiology Institute, Tualatin, Oregon 97062
Find articles by Ronald N Jones
Clyde Thornsberry
1Department of Pathology, Kaiser-Permanente Medical Care Program (Oregon Region), Clackamas, Oregon 97015; Centers for Disease Control, Atlanta, Georgia 30333; and The Clinical Microbiology Institute, Tualatin, Oregon 97062
Find articles by Clyde Thornsberry
Arthur L Barry
1Department of Pathology, Kaiser-Permanente Medical Care Program (Oregon Region), Clackamas, Oregon 97015; Centers for Disease Control, Atlanta, Georgia 30333; and The Clinical Microbiology Institute, Tualatin, Oregon 97062
Find articles by Arthur L Barry
1Department of Pathology, Kaiser-Permanente Medical Care Program (Oregon Region), Clackamas, Oregon 97015; Centers for Disease Control, Atlanta, Georgia 30333; and The Clinical Microbiology Institute, Tualatin, Oregon 97062
PMCID: PMC180061
This corrects the article "In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin." in volume 25 on page 710.